Spruce Biosciences, Inc. disclosed that Javier Szwarcberg, M.D., M.P.H., CEO, will speak at the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit. The company, trading under Nasdaq as SPRB, specializes in advanced therapies for neurological disorders. Dr. Szwarcberg's presentation will be in a fireside chat moderated by Madison El-Saadi, Ph.D., Healthcare Research Analyst. This event aims to address crucial medical needs, with a focus on cutting-edge solutions for such conditions.